REG - Versarien PLC - Directorate Changes

VersarienAnnouncement

18/07/2023 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230718:nRSR4187Ga&default-theme=true

RNS Number : 4187G  Versarien PLC  18 July 2023

18 July 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Directorate Changes

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased
to announce the appointment of Dr Stephen Hodge, currently the Company's Chief
Technology Officer, as the Company's Chief Executive Officer with immediate
effect.

 

Dr Stephen Hodge joined Versarien in 2017 and was appointed Head of Research
in July 2018, before being appointed to the Board as Chief Technology Officer
in January 2021.  Prior to this, he was employed as a Principal Engineer at
Cambridge Graphene Limited, a supplier of graphene inks and other graphene
materials, and a subsidiary of Versarien.  He has also held post-doctoral
research associate positions at the Cambridge Graphene Centre, a research
centre attached to the Department of Engineering at the University of
Cambridge, and in the Department of Chemistry at Imperial College London,
where he also completed a PhD in Nanomaterial Chemistry.

 

Stephen is a member of a number of advisory boards including holding the role
of Chairman of the Technical Working Group within the Graphene REACH
registration consortium.  Last year Dr Hodge was awarded the Royal Society of
Chemistry Rising Star in Industry Award 'for strategic leadership in
developing greener solutions and advocating for global regulations related to
the physical and toxicological testing of graphene'.

 

Resignation of Director

 

The Company has today received confirmation that Neill Ricketts has resigned
from the Board with effect from 14 July 2023 and is no longer a Director of
the Company.  He continues on garden leave with no day-to-day
responsibilities unless required by the Company.

 

Diane Savory, Non-executive Chair of Versarien, commented:

 

"I am very pleased that we are announcing the appointment of Stephen Hodge as
Versarien's Chief Executive Officer.  Stephen has been with Versarien for the
past six years during which time he has been instrumental in the development
of the Company's advanced materials technology and progressing our commercial
relationships.  I believe he is ideally placed to lead the Company as we
continue to progress our turnaround strategy and focus on the development and
commercialisation of Cementene™ and Graphene-Wear™.

 

"On behalf of the Board I would like to thank Neill Ricketts for his
contribution to the Company since its formation and we wish him well in his
future endeavours.

 

"We look forward to updating shareholders on the continuing progress with our
turnaround strategy in the coming months."

 

For further information please contact:

 

 Versarien                                                   c/o IFC

 Stephen Hodge, Chief Executive Officer

 Chris Leigh, Chief Financial Officer

 SP Angel Corporate Finance (Nominated Adviser and Broker)   +44 (0)20 3470 0470

 Matthew Johnson, Adam Cowl

 IFC Advisory Limited (Financial PR and Investor Relations)  +44 (0) 20 3934 6630

 Tim Metcalfe, Zach Cohen

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced
materials company focussed on specific sectors that will lead to a light
manufacturing and licensing model.

 

For further information please see: http://www.versarien.com
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.versarien.com%2F&data=05%7C01%7Ctwhitfield%40mclnews.com%7Ca6f36820d41746bbb8f008da42f2dd6a%7C7560185ee95f4d5a8cc0c244cb450a3e%7C0%7C0%7C637895909595351380%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=vp8yFEBNrElWqj0WOIqnwLTzPx3mbDopgjGylVz4v0c%3D&reserved=0)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOANKFBBPBKDFOD